Inducing tumor-intrinsic innate immune response to break cancer immunotherapy resistance - Top-Institutions - MDSpire

Inducing tumor-intrinsic innate immune response to break cancer immunotherapy resistance

  • By

  • Jessica A. Blandino

  • Takahiko Murayama

  • July 3, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Oncology

  • #3

    Vanderbilt University
    Vanderbilt University

    Nashville, Tennessee

    Key Differentiators

    • Oncology

  • #4

    Rutgers Cancer Institute of New Jersey
    Rutgers Cancer Institute of New Jersey

    New Brunswick, New Jersey

    Key Differentiators

    • Oncology

  • #5

    Center for Cancer Immune Therapy, Herlev Hospital
    Center for Cancer Immune Therapy, Herlev Hospital

    Herlev, Denmark

    Key Differentiators

    • Oncology

Original Source(s)

Inducing tumor-intrinsic innate immune response to break cancer immunotherapy resistance

  • by Jessica A. Blandino, Takahiko Murayama

  • July 3, 2026

Related Content

Immunotherapy does not impair ovarian function in a mouse model of breast cancer

The plasmacytoid dendritic cell paradox in cancer: impaired type I interferon responses in a nucleic acid–rich tumor microenvironment

Microbiome dysbiosis and its modulation in cancer development, prevention and therapy